When it comes to figuring out the best stocks to buy in any given month or year, crystal balls can be hazy, but our top Motley Fool contributors have scoured SEC filings, read industry trade journals, and crunched numbers to uncover three biotech stocks that they think could be among the top stocks to buy in February.Source: BioMarin.: The road […]
NEW YORK (CNNMoney)Gone are the days of excessive leverage and the dominance of Wall Street. Gone are the days when the stock market –and U.S. economy — had to be led by banks.”The U.S. economy is transitioning from a financial services economy into something much more real,” said Meredith Whitney, the former star Wall Street analyst who now helps run […]
It’s been shown that dividend-paying stocks outperform their non-dividend paying counterparts, but focusing on dividends may not be the best strategy when it comes to big biotech stocks. Read on to learn why three Motley Fool contributors don’t think it makes sense for these big biotech companies to pay investors a dividend.Cheryl Swanson : Take a little trip through history […]
It remains a time for caution. After a brief flurry of optimism this Monday the rest of the week went quite badly. Friday the indexes opened mixed, sold off until mid day, tried to rally til mid afternoon, and then a flurry of selling into the close. Not great. The S&P 500 fell 1.30% and the NASDAQ 1.03%. A lower […]
Joe Donohue is a full time trader with 25 years experience. He is a senior contributor and investor in Stocktwits and has been seen on CNN Money and quoted in Marketwatch, Forbes, Reuters, NY Times and Wall Street Journal.Joe takes a swing trading approach to the market and his holding period can be anywhere from a few days to a […]
Biotech stocks had a banner year in 2014. Agios Pharmaceuticals, Inc. (Nasdaq: AGIO ), Avanir Pharmaceuticals, Inc. (Nasdaq: AVNR ) and OvaScience, Inc. (Nasdaq: OVAS ), for example, each rose roughly 400%.Indeed, each year brings another set of home run stock picks in this sector, thanks to the twin pillars of FDA approval and promising clinical trial results.Trying to handicap […]
Black swan avalanche continues on Wall Street as markets continue to walk back last Thursday’s outsized gains in stocks.WASHINGTON, January 26, 2015 – Traders have been confronting a volatile market environment since the 2015 New Year Baby sent 2014’s tired Old Year codger packing. Oil prices, a change in congressional leadership, continued left-wing belligerence from a no-hugging-no-learning White House, chaos […]
Bloomberg
Jamie Dimon, CEO of J.P. Morgan
J.P. Morgan Chase CEO Jamie Dimon made waves last week, calling out the regulatory environment for banks as downright un-American.That kind of bluster is old hat for the top bank exec. Dimon was quick to position himself as the chief critic of bank regulation even as J.P. Morgan’s JPM, +0.32% peers Bank of America BAC, […]
Americans are feeling better about their job security and the economy, but most are theoretically only one paycheck away from the street.Approximately 62% of Americans have no emergency savings for things such as a $1,000 emergency room visit or a $500 car repair, according to a new survey of 1,000 adults by personal finance website Bankrate.com. Faced with an emergency, […]
By Joe Peta
At Novus we’ve examined the performance of many hundreds of hedge funds and we’ve found that, by far, the most important skill to possess is the ability to size positions effectively. That’s because unlike Exposure Management, and to a lesser degree Security Selection, the ability to size positions efficiently is the most persistent and consistent alpha-generating skill that a […]
